23,557 Shares in Vir Biotechnology, Inc. (NASDAQ:VIR) Bought by Marshall Wace LLP
Marshall Wace LLP purchased a new stake in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 23,557 shares of the company’s stock, valued at approximately $173,000. Several other hedge funds also recently added to or […]
Marshall Wace LLP purchased a new stake in Vir Biotechnology, Inc. (NASDAQ:VIR – Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 23,557 shares of the company’s stock, valued at approximately $173,000. Several other hedge funds also recently added to or […]
